Filing Details
- Accession Number:
- 0001179110-14-005757
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-24 18:14:14
- Reporting Period:
- 2014-03-21
- Filing Date:
- 2014-03-24
- Accepted Time:
- 2014-03-24 18:14:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1578990 | Ribeiro Oliveira De Claudia Hirawat | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-03-21 | 6,400 | $28.73 | 43,657 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-03-21 | 3,302 | $29.58 | 40,355 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-03-21 | 4,333 | $30.43 | 36,022 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-03-21 | 1,285 | $31.35 | 34,737 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 194 | Indirect | By spouse |
Footnotes
- The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 29, 2013 for the primary purpose of covering tax obligations associated with a restricted stock vesting event.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $28.08 to $29.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $29.15 to $30.14 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $30.22 to $31.01 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $31.23 to $31.53 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.